Anthony Romero
About Anthony Romero
Anthony Romero serves as the Senior Director and Head of Chemistry at ORIC Pharmaceuticals Inc., where he has worked since 2022. He has a robust background in medicinal chemistry, having held various leadership roles in prominent pharmaceutical companies, including Terns Pharmaceuticals and Genentech.
Current Role at ORIC Pharmaceuticals
Anthony Romero serves as the Senior Director and Head of Chemistry at ORIC Pharmaceuticals Inc. since 2022. In this role, he leads the chemistry department, overseeing research and development initiatives. He previously held the position of Director and Head of Chemistry at the same company from 2021 to 2022. His leadership contributes to the advancement of ORIC's drug discovery efforts in South San Francisco, California.
Previous Experience in Pharmaceutical Chemistry
Prior to his current role, Anthony Romero worked at Terns Pharmaceuticals as Director of Chemistry from 2018 to 2020. He led the BCR-Abl oncology program, which resulted in the identification of the clinical candidate TRN-632, an allosteric inhibitor partnered with Hansoh Pharma. He also held positions at UNITY Biotechnology and Genentech, where he contributed to various chemistry initiatives and programs.
Educational Background in Chemistry
Anthony Romero earned a Ph.D. in Medicinal Chemistry from The University of Kansas, where he studied from 2000 to 2004. He also holds a Master of Science in Medicinal Chemistry from the same institution, achieved between 1998 and 2000. Additionally, he completed his undergraduate studies in Chemistry at Occidental College, obtaining an A.B. degree from 1994 to 1998.
Contributions to Chemistry Initiatives
At ORIC Pharmaceuticals, Anthony Romero has chaired the culture club committee, contributing to the company's cultural initiatives. He has also developed workflows for fragment-based screening at Merck, utilizing various techniques to identify fragment hits. His experience includes coordinating the Discovery Chemistry Intern Program at Genentech, where he oversaw the hiring process for interns.
Research and Development Expertise
Anthony Romero has extensive experience in managing proprietary fragment libraries and designing new molecules. At Merck, he collaborated with a CRO for library expansion and developed workflows for fragment-based screening. His expertise encompasses various techniques, including HCS, biacore, NMR, and x-ray, which he has applied in both academic and industry settings.